Molecular weight : 4113.58
Semaglutide a glucagon-like peptide-1 receptor agonist, it lowers the blood sugar level by
, and phase 3 was completed in 2016. FDA approval was applied in December 2016
Researchers at the University of Leeds reported in 2017 that it can also be used for the
